胰腺癌
癌症研究
医学
急性胰腺炎
病理
胰瘘
药理学
成纤维细胞
外科
瘘管
胰腺肿瘤
肿瘤微环境
胰蛋白酶
治疗效果
病态的
药物输送
酶
内科学
促炎细胞因子
胰腺炎
炎症
作者
Mengbin Ding,Baoli Zhou,Yijing Zhang,Yuhan Zhang,Xinting Liu,Yulu Hu,Tianze Du,Yong Kang,Li Wang,Xiaoyuan Ji
摘要
Postoperative management of pancreatic ductal adenocarcinoma (PDAC) remains hindered by two closely linked challenges: the harmful effects of pancreatic fistula and the high risk of local tumor recurrence. Although leaked pancreatic fluid (PF) is generally regarded as a postoperative complication, its abundance of digestive enzymes also suggests an underexplored therapeutic opportunity. Here, we developed a localized therapeutic strategy that converts the enzyme-rich fistula microenvironment from a pathological burden into an antitumor resource. To achieve this, we nano-engineered Bacteroides thetaiotaomicron (B.t.) and integrated it with TRPV1 antagonist-loaded nanomicelles in a GelMA hydrogel, generating the platform TNPs-N@B.t. + Gel. Mechanistically, this system acts in a coordinated manner within the postoperative PDAC microenvironment. B.t. degrades tumor-associated mucins, thereby dismantling the protective barrier that shields PDAC cells from pancreatic enzymes and restoring their vulnerability to enzymatic attack. Meanwhile, PF forms an in situ digestive enzyme corona on the nanoengineered bacterial surface, which promotes deeper tumor penetration by disrupting intercellular adhesion. In parallel, delivery of the TRPV1 antagonist (TRPV1a) suppresses CGRP release, attenuates cancer-associated fibroblast (CAF) activation, and facilitates NK-cell-associated antitumor responses. In postoperative PDAC models, TNPs-N@B.t. + Gel showed durable local retention, enhanced tumor accumulation, suppressed recurrence, prolonged survival, and alleviated pain-related behaviors without evident systemic toxicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI